Ignite Creation Date:
2024-05-05 @ 11:39 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00097409
Status:
COMPLETED
Last Update Posted:
2010-10-04
First Post:
2004-11-23
Brief Title:
Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian Cancer
Sponsor:
GlaxoSmithKline
Organization:
GlaxoSmithKline